| __timestamp | Axsome Therapeutics, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 1271353000 |
| Thursday, January 1, 2015 | 6776987 | 1620577000 |
| Friday, January 1, 2016 | 21199860 | 2052295000 |
| Sunday, January 1, 2017 | 19957616 | 2075142000 |
| Monday, January 1, 2018 | 23495055 | 2186100000 |
| Tuesday, January 1, 2019 | 53647067 | 3036600000 |
| Wednesday, January 1, 2020 | 70244579 | 2735000000 |
| Friday, January 1, 2021 | 58060725 | 2908100000 |
| Saturday, January 1, 2022 | 57947447 | 3592500000 |
| Sunday, January 1, 2023 | 97944000 | 4439000000 |
| Monday, January 1, 2024 | 187077000 | 5132000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Regeneron Pharmaceuticals, Inc. and Axsome Therapeutics, Inc. exemplify two distinct approaches to research and development (R&D) spending. Over the past decade, Regeneron has consistently invested heavily in R&D, with expenditures peaking at approximately $4.4 billion in 2023, marking a 250% increase since 2014. This commitment underscores their strategy of maintaining a robust pipeline of groundbreaking therapies.
Conversely, Axsome Therapeutics, while smaller in scale, has shown a remarkable growth trajectory in R&D spending, increasing by over 2,000% from 2014 to 2023. This surge reflects their aggressive push to innovate and expand their portfolio. Despite the disparity in absolute spending, both companies demonstrate a steadfast dedication to innovation, albeit on different scales. This comparison highlights the diverse strategies within the pharmaceutical industry to prioritize and achieve innovation.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alnylam Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Regeneron Pharmaceuticals, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and ImmunityBio, Inc.
Regeneron Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Regeneron Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How BeiGene, Ltd. and Axsome Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Exelixis, Inc. vs Axsome Therapeutics, Inc.
Comparing Innovation Spending: Axsome Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Dynavax Technologies Corporation
Research and Development Investment: Axsome Therapeutics, Inc. vs Celldex Therapeutics, Inc.